Aricogan, 5 mg, tablets
Aricogan, 10 mg, tablets
Aricogan, 15 mg, tablets
Aricogan, 30 mg, tablets
(Aripiprazole)
You should carefully read the contents of the leaflet before taking the medicine, as it contains important information for the patient.
Aricogan contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults and adolescents aged 15 years and older with a disease characterized by symptoms such as hearing, seeing, and feeling phenomena that do not exist in reality, suspiciousness, beliefs that are inconsistent with reality, incoherent speech and behavior, and emotional numbness. Patients with these symptoms may also experience sadness, anxiety, or tension, as well as feelings of guilt.
Aricogan is used to treat adults and adolescents aged 13 years and older with symptoms such as severe excitement, overwhelming energy, much reduced need for sleep, very rapid speech, racing thoughts, and sometimes very severe irritability. In adults, the medicine prevents the recurrence of these symptoms in patients who have responded to treatment with Aricogan.
Before starting to take Aricogan, you should discuss it with your doctor.
During treatment with aripiprazole, cases of suicidal thoughts and behaviors have been reported. You should immediately inform your doctor if you experience thoughts or feelings of self-harm.
Before taking Aricogan, you should consult your doctor if you have any of the following symptoms:
If you notice weight gain, involuntary movements, drowsiness that interferes with your daily activities, difficulty swallowing, or allergic symptoms, you should consult your doctor.
If an elderly patient has dementia (loss of memory and other mental abilities), the patient, their caregiver, or relative should inform the doctor if the patient has had a stroke or "mini" stroke in the past.
You should immediately inform your doctor if you experience thoughts or feelings of self-harm. Suicidal thoughts and behaviors have been reported during treatment with aripiprazole.
You should immediately inform your doctor if you experience muscle stiffness or stiffness with high fever, sweating, changes in mental status, or rapid or irregular heartbeat.
You should inform your doctor if you or your relatives notice behaviors that are the result of irresistible impulse, temptation, or compulsion to perform certain unusual actions that may be harmful to you or others. These phenomena are called impulse control disorders and may manifest as behaviors such as:
Aripiprazole may cause drowsiness, a sudden drop in blood pressure when changing position to standing, dizziness, and movement and balance disorders that can cause falls. You should be particularly careful in the case of elderly or weakened patients.
This medicine should not be used in children and adolescents under the age of 13. It is not known if it is safe and effective in this group of patients.
You should tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take, including those available without a prescription.
Blood pressure-lowering medicines: Aricogan may increase the effect of medicines used to lower blood pressure. You should inform your doctor that you are taking blood pressure-lowering medicines.
Taking Aricogan with certain medicines may require a change in the dose of Aricogan or other medicines. You should definitely inform your doctor, especially when taking the following medicines:
These medicines may increase the risk of side effects or reduce the effect of Aricogan. If you experience any unusual symptoms while taking these medicines with Aricogan, you should consult your doctor.
Medicines that increase serotonin levels are usually used to treat disorders such as depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
Aricogan can be taken with or without food.
You should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
The following symptoms may occur in newborns of mothers who took Aricogan during the last trimester of pregnancy (last three months of pregnancy): tremors, muscle stiffness, and (or) weakness, drowsiness, agitation, breathing difficulties, feeding difficulties. If any of these symptoms are observed in the child, you should contact a doctor.
In the case of taking Aricogan, your doctor will discuss with you whether you should breastfeed, taking into account the benefits of treatment for you and the benefits of breastfeeding for your child. You should not breastfeed while taking this medicine. You should discuss with your doctor the best way to feed your child if you are taking this medicine.
While taking this medicine, dizziness and vision disturbances may occur (see section 4). You should take this into account in situations where full alertness is required, e.g., when driving a vehicle or operating machines.
If you have an intolerance to some sugars, you should consult your doctor before taking this medicine.
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, you should ask your doctor or pharmacist.
The recommended dose for adults is 15 mg once a day.However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
Treatment with Aricogan can be started with a low dose, using an oral solution. The dose can be gradually increased to the recommended dose for adolescents of 10 mg once a day.However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
If you feel that the effect of Aricogan is too weak or too strong, you should consult your doctor or pharmacist.
You should try to take Aricogan at the same time every day.
The medicine can be taken with or without food. You should always swallow the tablets whole with water.
Even if you feel better, you should not change the dose or stop taking the medicine without consulting your doctor.
If you have taken more Aricogan than recommended (or if someone else has taken the medicine not intended for them), you should immediately contact a doctor. If you cannot contact a doctor, you should go to the nearest hospital, taking the medicine packaging with you.
In patients who have taken too much aripiprazole, the following symptoms have occurred:
Other symptoms may include:
If you experience any of these symptoms, you should immediately contact a doctor or go to the nearest hospital.
If you miss a dose of Aricogan, you should take it as soon as possible. You should not take a double dose to make up for the missed dose.
You should not stop treatment just because you feel better. It is important to take Aricogan for as long as your doctor has prescribed it.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Aricogan can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
The following side effects have been reported after the marketing of aripiprazole in oral form, but the frequency of their occurrence is not known (cannot be estimated from the available data):
In elderly patients with dementia taking aripiprazole, more cases of fatal outcomes have been reported. Additionally, there are reports of stroke or "mini" stroke.
In adolescents aged 13 years and older, side effects have occurred with a similar frequency and type as in adults, with the exception of drowsiness, involuntary trembling or jerking movements, restlessness, and fatigue, which have occurred very frequently (more frequently than in 1 in 10 patients) and abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, tremors, involuntary movements of the limbs, and dizziness, especially when standing up from a lying or sitting position, which have occurred frequently (more frequently than in 1 in 100 patients).
If you experience any side effects, including any side effects not mentioned in the leaflet, you should tell your doctor or pharmacist or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the month stated.
This medicine does not require special storage conditions regarding temperature.
Store in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Aricogan 5 mg, tablets
Indigo carmine (E 132)
Aricogan 10 mg, tablets
Red iron oxide (E 172)
Aricogan 15 mg, tablets
Yellow iron oxide (E 172)
Aricogan 30 mg, tablets
Red iron oxide (E 172)
Aricogan 5 mg, tablets
Tablets are blue, speckled, rectangular, and have the inscription "250" on one side, and are smooth on the other side. Dimensions: 8.1 mm x 4.6 mm.
Aricogan 10 mg, tablets
Tablets are pink, speckled, rectangular, and have the inscription "252" on one side, and are smooth on the other side. Dimensions: 8.1 mm x 4.6 mm.
Aricogan 15 mg, tablets
Tablets are yellow, speckled, round with beveled edges, and have the inscription "253" on one side, and are smooth on the other side. Diameter: 7.3 mm.
Aricogan 30 mg, tablets
Tablets are pink, speckled, round with beveled edges, and have the inscription "L255" on one side, and are smooth on the other side. Diameter: 9.1 mm.
Aricogan is packaged in OPA/Aluminum/PVC/Aluminum blisters in cardboard boxes containing 28, 30, 56, 60 tablets.
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
GE Pharmaceuticals Ltd.
Industrial Zone “Chekanitza-South” area,
2140 Botevgrad
Bulgaria
To obtain more detailed information, you should contact the representative of the marketing authorization holder:
G.L. PHARMA POLAND Sp. z o.o.
Al. Jana Pawła II 61/313
01-031 Warsaw, Poland
Tel: 022/ 636 52 23; 636 53 02
biuro@gl-pharma.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.